Literature DB >> 21232591

Fatal hemorrhage induced by subtilase cytotoxin from Shiga-toxigenic Escherichia coli.

Takeshi Furukawa1, Kinnosuke Yahiro, Atsushi B Tsuji, Yasuhiro Terasaki, Naoko Morinaga, Masaru Miyazaki, Yuh Fukuda, Tsuneo Saga, Joel Moss, Masatoshi Noda.   

Abstract

Subtilase cytotoxin (SubAB) is an AB(5) type toxin produced by a subset of Shiga-toxigenic Escherichia coli. The A subunit is a subtilase-like serine protease and cleaves an endoplasmic reticulum chaperone BiP. The B subunit binds to a receptor on the cell surface. Although SubAB is lethal for mice, the cause of death is not clear. In this study, we demonstrate in mice that SubAB induced small bowel hemorrhage and a coagulopathy characterized by thrombocytopenia, prolonged prothrombin time and activated partial thromboplastin time. SubAB also induced inflammatory changes in the small intestine as detected by ¹⁸F-fluoro-2-deoxy-d-glucose positron emission tomography imaging and histochemical analysis. Using RT-PCR and ELISA, SubAB was shown to increase interleukin-6 in a time-dependent manner. Thus, our results indicate that death in SubAB-treated mice may be associated with severe inflammatory response and hemorrhage of the small intestine, accompanied by coagulopathy and IL6 production.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232591      PMCID: PMC3385872          DOI: 10.1016/j.micpath.2011.01.002

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  33 in total

1.  Identification and characterization of receptors for vacuolating activity of subtilase cytotoxin.

Authors:  Kinnosuke Yahiro; Naoko Morinaga; Mamoru Satoh; Gen Matsuura; Takeshi Tomonaga; Fumio Nomura; Joel Moss; Masatoshi Noda
Journal:  Mol Microbiol       Date:  2006-09-08       Impact factor: 3.501

2.  AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP.

Authors:  Adrienne W Paton; Travis Beddoe; Cheleste M Thorpe; James C Whisstock; Matthew C J Wilce; Jamie Rossjohn; Ursula M Talbot; James C Paton
Journal:  Nature       Date:  2006-10-05       Impact factor: 49.962

3.  Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum.

Authors:  Hui Wang; James C Paton; Adrienne W Paton
Journal:  J Infect Dis       Date:  2007-08-22       Impact factor: 5.226

Review 4.  Collagen receptor signalling in platelets: extending the role of the ITAM.

Authors:  S P Watson; J Gibbins
Journal:  Immunol Today       Date:  1998-06

Review 5.  FDG PET of infection and inflammation.

Authors:  Charito Love; Maria B Tomas; Gene G Tronco; Christopher J Palestro
Journal:  Radiographics       Date:  2005 Sep-Oct       Impact factor: 5.333

6.  Impact of antibiotic stress on acid and heat tolerance and virulence factor expression of Escherichia coli O157:H7.

Authors:  Reha Onur Azizoglu; Maryanne Drake
Journal:  J Food Prot       Date:  2007-01       Impact factor: 2.077

7.  Impact of animal handling on the results of 18F-FDG PET studies in mice.

Authors:  Barbara J Fueger; Johannes Czernin; Isabel Hildebrandt; Chris Tran; Benjamin S Halpern; David Stout; Michael E Phelps; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

Review 8.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Authors:  G J Cook; I Fogelman; M N Maisey
Journal:  Semin Nucl Med       Date:  1996-10       Impact factor: 4.446

Review 9.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors:  Hongming Zhuang; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

10.  Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice.

Authors:  S Franckhauser; I Elias; V Rotter Sopasakis; T Ferré; I Nagaev; C X Andersson; J Agudo; J Ruberte; F Bosch; U Smith
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

View more
  14 in total

1.  Uptake of Shiga-toxigenic Escherichia coli SubAB by HeLa cells requires an actin- and lipid raft-dependent pathway.

Authors:  Sayaka Nagasawa; Kohei Ogura; Hiroyasu Tsutsuki; Hisako Saitoh; Joel Moss; Hirotaro Iwase; Masatoshi Noda; Kinnosuke Yahiro
Journal:  Cell Microbiol       Date:  2014-06-17       Impact factor: 3.715

2.  Type Three Secretion System-Dependent Microvascular Thrombosis and Ischemic Enteritis in Human Gut Xenografts Infected with Enteropathogenic Escherichia coli.

Authors:  Einat Nissim-Eliraz; Eilam Nir; Irit Shoval; Noga Marsiano; Israel Nissan; Hadar Shemesh; Nandor Nagy; Allan M Goldstein; Michael Gutnick; Ilan Rosenshine; Simcha Yagel; Nahum Y Shpigel
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 3.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

4.  Regulation of subtilase cytotoxin-induced cell death by an RNA-dependent protein kinase-like endoplasmic reticulum kinase-dependent proteasome pathway in HeLa cells.

Authors:  Kinnosuke Yahiro; Hiroyasu Tsutsuki; Kohei Ogura; Sayaka Nagasawa; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

5.  Controlled Delivery of an Anti-Inflammatory Toxin to Macrophages by Mutagenesis and Nanoparticle Modification.

Authors:  Ayaka Harada; Hiroyasu Tsutsuki; Tianli Zhang; Kinnosuke Yahiro; Tomohiro Sawa; Takuro Niidome
Journal:  Nanomaterials (Basel)       Date:  2022-06-23       Impact factor: 5.719

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Differential effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on chemokine and proinflammatory cytokine expression in human macrophage, colonic epithelial, and brain microvascular endothelial cell lines.

Authors:  Hui Wang; Trisha J Rogers; James C Paton; Adrienne W Paton
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

8.  Subtilase cytotoxin enhances Escherichia coli survival in macrophages by suppression of nitric oxide production through the inhibition of NF-κB activation.

Authors:  Hiroyasu Tsutsuki; Kinnosuke Yahiro; Kotaro Suzuki; Akira Suto; Kohei Ogura; Sayaka Nagasawa; Hideshi Ihara; Takeshi Shimizu; Hiroshi Nakajima; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

9.  Mechanism of inhibition of Shiga-toxigenic Escherichia coli SubAB cytotoxicity by steroids and diacylglycerol analogues.

Authors:  Kinnosuke Yahiro; Sayaka Nagasawa; Kimitoshi Ichimura; Hiroki Takeuchi; Kohei Ogura; Hiroyasu Tsutsuki; Takeshi Shimizu; Sunao Iyoda; Makoto Ohnishi; Hirotaro Iwase; Joel Moss; Masatoshi Noda
Journal:  Cell Death Discov       Date:  2018-02-14

10.  Duplication and diversification of a unique chromosomal virulence island hosting the subtilase cytotoxin in Escherichia coli ST58.

Authors:  Ethan R Wyrsch; Piklu Roy Chowdhury; Veronica M Jarocki; Kate J Brandis; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.